PRL and breast cancer: Alterations in tumor metabolism were also observed through global untargeted metabolomics and high-resolution spatial metabolomics, with pathways such as breast cancer, prolactin signaling, histidine metabolism, ovarian steroidogenesis, cysteine and methionine metabolism, and estrogen signaling being significantly altered in CC with LNM.